ZA948669B - New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions - Google Patents

New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions

Info

Publication number
ZA948669B
ZA948669B ZA948669A ZA948669A ZA948669B ZA 948669 B ZA948669 B ZA 948669B ZA 948669 A ZA948669 A ZA 948669A ZA 948669 A ZA948669 A ZA 948669A ZA 948669 B ZA948669 B ZA 948669B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical compositions
carboxamide derivatives
pyrazine carboxamide
new pyrazine
Prior art date
Application number
ZA948669A
Other languages
English (en)
Inventor
Otto Roos
Georg Speck
Walter Loesel
Dietrich Arndts
Wolf-Dietrich Bechtel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA948669B publication Critical patent/ZA948669B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA948669A 1993-11-04 1994-11-03 New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions ZA948669B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4337609A DE4337609A1 (de) 1993-11-04 1993-11-04 Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln

Publications (1)

Publication Number Publication Date
ZA948669B true ZA948669B (en) 1995-07-04

Family

ID=6501757

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948669A ZA948669B (en) 1993-11-04 1994-11-03 New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions

Country Status (17)

Country Link
EP (1) EP0726899B1 (ko)
JP (1) JPH09505035A (ko)
KR (1) KR960705815A (ko)
CN (1) CN1134151A (ko)
AT (1) ATE188965T1 (ko)
AU (1) AU690588B2 (ko)
CA (1) CA2175837A1 (ko)
CO (1) CO4290432A1 (ko)
DE (2) DE4337609A1 (ko)
DK (1) DK0726899T3 (ko)
ES (1) ES2140565T3 (ko)
GR (1) GR3033034T3 (ko)
NZ (1) NZ274848A (ko)
PL (1) PL314187A1 (ko)
PT (1) PT726899E (ko)
WO (1) WO1995012592A1 (ko)
ZA (1) ZA948669B (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19548812A1 (de) * 1995-12-27 1997-07-03 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
DE19738604A1 (de) * 1997-09-04 1999-03-11 Hoechst Marion Roussel De Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe
WO2000075115A1 (fr) 1999-06-03 2000-12-14 Takeda Chemical Industries, Ltd. Preparations s'administrant par voie nasale
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
MXPA04010288A (es) 2002-04-19 2005-05-17 Cellular Genomics Inc Imidazo[1,2-a]pirazin-8-ilaminas, y metodos para su fabricacion y usos.
AU2003270489A1 (en) 2002-09-09 2004-03-29 Cellular Genomics, Inc. 6-ARYL-IMIDAZO(1,2-a)PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
WO2004072081A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
WO2005014599A1 (en) 2003-06-04 2005-02-17 Cellular Genomics, Inc. Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
US7393848B2 (en) 2003-06-30 2008-07-01 Cgi Pharmaceuticals, Inc. Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
BRPI0412285A (pt) 2003-07-02 2006-09-19 Hoffmann La Roche os compostos de quinazolinona substituìda por arilamina
US7259164B2 (en) 2003-08-11 2007-08-21 Cgi Pharmaceuticals, Inc. Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
WO2005030776A1 (en) 2003-09-23 2005-04-07 Vertex Pharmaceuticals Incorporated Pyrazolopyrrole derivatives as protein kinase inhibitors
US7777040B2 (en) 2005-05-03 2010-08-17 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
US20090221612A1 (en) 2008-02-13 2009-09-03 Mitchell Scott A Certain substituted amides, method of making, and method of use thereof
ES2744541T3 (es) 2008-12-08 2020-02-25 Gilead Connecticut Inc Inhibidores de imidazopirazina Syk
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
PE20140975A1 (es) 2008-12-08 2014-08-25 Gilead Connecticut Inc Derivados de imidazopirazina como inhibidores de syk
US9562056B2 (en) 2010-03-11 2017-02-07 Gilead Connecticut, Inc. Imidazopyridines Syk inhibitors
BR112013005823B8 (pt) * 2010-09-13 2022-11-22 Otsuka Pharma Co Ltd Compostos heterocíclicos para o tratamento ou prevenção de distúrbios causados pela neurotransmissão reduzida de serotonina, norefnefrina ou dopamina
MY176803A (en) 2013-07-30 2020-08-21 Gilead Connecticut Inc Polymorph of syk inhibitors
EA201690127A1 (ru) 2013-07-30 2016-07-29 Джилид Коннектикут, Инк. Состав на основе ингибиторов syk
CN103467392B (zh) * 2013-10-09 2016-08-17 重庆工商大学 一种多卤代吡嗪甲酰胺衍生物及其盐类、制备方法和用途
CN105764516A (zh) 2013-12-04 2016-07-13 吉利德科学公司 治疗癌症的方法
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
SG11201610551TA (en) 2014-07-14 2017-01-27 Gilead Sciences Inc Combinations for treating cancers
CN111051311A (zh) 2017-08-25 2020-04-21 吉利德科学公司 Syk抑制剂的多晶型物
US11339168B2 (en) 2019-02-22 2022-05-24 Kronos Bio, Inc. Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299931A (ko) * 1962-10-30
TW213903B (ko) * 1991-08-16 1993-10-01 Boehringer Ingelheim Kg

Also Published As

Publication number Publication date
ATE188965T1 (de) 2000-02-15
DE4337609A1 (de) 1995-05-11
PL314187A1 (en) 1996-09-02
AU690588B2 (en) 1998-04-30
DE59409094D1 (de) 2000-02-24
NZ274848A (en) 1998-03-25
EP0726899B1 (de) 2000-01-19
EP0726899A1 (de) 1996-08-21
KR960705815A (ko) 1996-11-08
JPH09505035A (ja) 1997-05-20
WO1995012592A1 (de) 1995-05-11
AU7993694A (en) 1995-05-23
PT726899E (pt) 2000-04-28
CA2175837A1 (en) 1995-05-11
CN1134151A (zh) 1996-10-23
DK0726899T3 (da) 2000-06-26
CO4290432A1 (es) 1996-04-17
GR3033034T3 (en) 2000-08-31
ES2140565T3 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
TW369521B (en) Androstenone derivative
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
JO1502B1 (en) New pharmacy vehicles
MY132705A (en) Novel compounds with analgesic effect
AU5431390A (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
MY115211A (en) Novel amino acid derivatives, their preparation and use
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
GEP19981357B (en) New Adenozine Derivatives, Prepatation Methods and Pharmaceutical Composit¬i¬ons Containing Them
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
GEP20032968B (en) Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis
GEP20022613B (en) Compositions with Beneficial Organoleptic Properties and Their Solvates, Method for Their Production and Pharmaceutical Compound Containing the Same
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
CA2138288A1 (en) Substituted azabicycloheptane derivatives, their preparation and use
CA2176962A1 (en) N-substituted azabicycloheptane derivatives, their preparation and use
JO1531B1 (en) New near-compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
MX9710466A (es) Compuestos de estilbeno que contienen un grupo adamantilo, composiciones que los contienen y sus usos.